Today's pharmaceutical companies face increasingly complex business, political, regulatory, and legal issues, including those related to patents, generic drugs, clinical trials, compliance, fraud and abuse investigations, licensure, reimbursements, marketing, HIPAA privacy, and joint ventures. We help our pharmaceutical clients strategically assess risk and opportunity.
For a list of published opinions, please click here.
